Austar Lifesciences Balance Sheet Health
Financial Health criteria checks 3/6
Austar Lifesciences has a total shareholder equity of CN¥775.5M and total debt of CN¥430.7M, which brings its debt-to-equity ratio to 55.5%. Its total assets and total liabilities are CN¥2.2B and CN¥1.4B respectively.
Key information
55.5%
Debt to equity ratio
CN¥430.68m
Debt
Interest coverage ratio | n/a |
Cash | CN¥173.77m |
Equity | CN¥775.47m |
Total liabilities | CN¥1.38b |
Total assets | CN¥2.16b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AULS.F's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: AULS.F's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥205.8M).
Debt to Equity History and Analysis
Debt Level: AULS.F's net debt to equity ratio (33.1%) is considered satisfactory.
Reducing Debt: AULS.F's debt to equity ratio has increased from 5.4% to 55.5% over the past 5 years.
Debt Coverage: AULS.F's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if AULS.F's interest payments on its debt are well covered by EBIT.